{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:55:27Z","timestamp":1792090527501,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hyperuricemia increases morbidity and mortality in type 2 diabetic individuals. It is linked to the expansion of diabetes and cardiovascular diseases indicators, as well as being a significant predictor of coronary artery disease. It also leads to a poor prognosis and increment of diabetic complications including diabetic neuropathy, retinopathy, and nephropathy. Therefore, this systematic review and meta-analysis was aimed to determine the pooled prevalence of hyperuricemia among type 2 diabetes mellitus patients in Africa.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a systematic review and meta-analysis following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. To identify relevant articles, we searched electronic databases such as PubMed, Google Scholar, African Journal Online, Science Direct, Embase, ResearchGate, Scopus, and Web of Sciences. The quality of the included studies was assessed using the Newcastle-Ottawa Quality Assessment Scale. Statistical analysis was performed using Stata 14.0 software. To evaluate heterogeneity, we utilized Cochran\u2019s Q test and I<jats:sup>2<\/jats:sup> statistics. Publication bias was assessed through the examination of a funnel plot and Egger\u2019s test. The pooled prevalence was estimated using a random effect model. Furthermore, sub-group and sensitivity analyses were conducted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The overall pooled prevalence of hyperuricemia among type 2 diabetic patients in Africa was 27.28% (95% CI: 23.07, 31.49). The prevalence was highest in Central Africa 33.72% (95% CI: 23.49, 43.95), and lowest in North Africa 24.72% (95% CI: 14.38, 35.07). Regarding sex, the pooled prevalence of hyperuricemia among female and male type 2 diabetic patients was 28.02% (95% CI: 22.92, 33.48) and 28.20% (95% CI: 22.92, 33.48), respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This systematic review and meta-analysis showed a high prevalence of hyperuricemia among type 2 diabetic patients. So, regular screening and diagnosis of hyperuricemia required for preventing its pathological effects and contribution to chronic complications of diabetes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic review registration<\/jats:title>\n                <jats:p>: PROSPERO (2022: CRD42022331279).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-023-01408-0","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T04:02:24Z","timestamp":1689652944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Prevalence of hyperuricemia among type 2 diabetes mellitus patients in Africa: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Ermiyas","family":"Alemayehu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temesgen","family":"Fiseha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew Mesfin","family":"Bambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Sahile Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habtye","family":"Bisetegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihret","family":"Tilahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habtu","family":"Debash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussen","family":"Ebrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousman","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melaku Ashagrie","family":"Belete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alemu","family":"Gedefie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,18]]},"reference":[{"issue":"Suppl 1","key":"1408_CR1","first-page":"62","volume":"33","author":"G Rossi","year":"2018","unstructured":"Rossi G, Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2018;33(Suppl 1):62\u2013S9.","journal-title":"Diabetes Care"},{"issue":"1","key":"1408_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00125-015-3789-z","volume":"59","author":"RD Leslie","year":"2016","unstructured":"Leslie RD, Palmer J, Schloot NC, Lernmark A. Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment. Diabetologia. 2016;59(1):13\u201320.","journal-title":"Diabetologia"},{"issue":"4","key":"1408_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jegh.2015.05.003","volume":"5","author":"R Ramtahal","year":"2015","unstructured":"Ramtahal R, Khan C, Maharaj-Khan K, Nallamothu S, Hinds A, Dhanoo A, et al. Prevalence of self-reported sleep duration and sleep habits in type 2 diabetes patients in South Trinidad. J Epidemiol global health. 2015;5(4):35\u2013S43.","journal-title":"J Epidemiol global health"},{"issue":"3","key":"1408_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00125-018-4763-3","volume":"62","author":"CC Patterson","year":"2019","unstructured":"Patterson CC, Harjutsalo V, Rosenbauer J, Neu A, Cinek O, Skrivarhaug T, et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 european centres in the 25 year period 1989\u20132013: a multicentre prospective registration study. Diabetologia. 2019;62(3):408\u201317.","journal-title":"Diabetologia"},{"key":"1408_CR5","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7785","key":"1408_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","volume":"576","author":"M Roden","year":"2019","unstructured":"Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature. 2019;576(7785):51\u201360.","journal-title":"Nature"},{"issue":"1\u20132","key":"1408_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2991\/j.jegh.2017.11.004","volume":"8","author":"EM Onyango","year":"2018","unstructured":"Onyango EM, Onyango BM. The rise of noncommunicable diseases in Kenya: an examination of the time trends and contribution of the changes in diet and physical inactivity. J Epidemiol global health. 2018;8(1\u20132):1.","journal-title":"J Epidemiol global health"},{"issue":"32","key":"1408_CR8","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.2174\/138161205774913255","volume":"11","author":"G Glantzounis","year":"2005","unstructured":"Glantzounis G, Tsimoyiannis E, Kappas A, Galaris D. Uric acid and oxidative stress. Curr Pharm Design. 2005;11(32):4145\u201351.","journal-title":"Curr Pharm Design"},{"issue":"6\u20137","key":"1408_CR9","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/15257770802138558","volume":"27","author":"YY Sautin","year":"2008","unstructured":"Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides and Nucleic Acids. 2008;27(6\u20137):608\u201319.","journal-title":"Nucleosides Nucleotides and Nucleic Acids"},{"issue":"5","key":"1408_CR10","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/oxfordjournals.molbev.a004123","volume":"19","author":"M Oda","year":"2002","unstructured":"Oda M, Satta Y, Takenaka O, Takahata N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol. 2002;19(5):640\u201353.","journal-title":"Mol Biol Evol"},{"issue":"12","key":"1408_CR11","first-page":"148","volume":"3","author":"TMV Rao","year":"2016","unstructured":"Rao TMV, Vanukuri NK. A study on serum uric acid levels in type 2 diabetes mellitus and its association with cardiovascular risk factors. IAIM. 2016;3(12):148\u201355.","journal-title":"IAIM"},{"issue":"6","key":"1408_CR12","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI42344","volume":"120","author":"A So","year":"2010","unstructured":"So A, Thorens B. Uric acid transport and disease. J Clin Investig. 2010;120(6):1791\u20139.","journal-title":"J Clin Investig"},{"issue":"10","key":"1408_CR13","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/eurheartj\/ehi879","volume":"27","author":"C Ruggiero","year":"2006","unstructured":"Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, et al. Uric acid and inflammatory markers. Eur Heart J. 2006;27(10):1174\u201381.","journal-title":"Eur Heart J"},{"issue":"7","key":"1408_CR14","first-page":"28","volume":"60","author":"A Agarwal","year":"2012","unstructured":"Agarwal A, Singh M, Arya V, Garg U, Singh VP, Jain V. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors. J Assoc Physicians India. 2012;60(7):28\u201332.","journal-title":"J Assoc Physicians India"},{"issue":"9","key":"1408_CR15","first-page":"82","volume":"14","author":"S Khare","year":"2015","unstructured":"Khare S, Vishandasani JK, Kansal A. To study serum uric acid in type 2 diabetes mellitus patient. IOSR J Dent Med Sci. 2015;14(9):82\u20136.","journal-title":"IOSR J Dent Med Sci"},{"key":"1408_CR16","unstructured":"Kashinath R, Nagendra S, Srinivas S. Hyperuricemia in type 2 diabetes Mellitus. Global J Med Res. 2014;14(3)."},{"issue":"9","key":"1408_CR17","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2337\/dc09-0288","volume":"32","author":"S Kodama","year":"2009","unstructured":"Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32(9):1737\u201342.","journal-title":"Diabetes Care"},{"issue":"1","key":"1408_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2369-15-122","volume":"15","author":"L Li","year":"2014","unstructured":"Li L, Yang C, Zhao Y, Zeng X, Liu F, Fu P. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies. BMC Nephrol. 2014;15(1):1\u201312.","journal-title":"BMC Nephrol"},{"issue":"5","key":"1408_CR19","doi-asserted-by":"publisher","first-page":"C1183","DOI":"10.1152\/ajpcell.00075.2008","volume":"295","author":"S Zharikov","year":"2008","unstructured":"Zharikov S, Krotova K, Hu H, Baylis C, Johnson RJ, Block ER, et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiology-Cell Physiol. 2008;295(5):C1183\u2013C90.","journal-title":"Am J Physiology-Cell Physiol"},{"issue":"6","key":"1408_CR20","doi-asserted-by":"publisher","first-page":"F991","DOI":"10.1152\/ajprenal.00283.2001","volume":"282","author":"M Mazzali","year":"2002","unstructured":"Mazzali M, Kanellis J, Han L, Feng L, Xia Y-Y, Chen Q, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiology-Renal Physiol. 2002;282(6):F991\u2013F7.","journal-title":"Am J Physiology-Renal Physiol"},{"issue":"5","key":"1408_CR21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1159\/000105142","volume":"27","author":"KM Talaat","year":"2007","unstructured":"Talaat KM, El-Sheikh AR. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am J Nephrol. 2007;27(5):435\u201340.","journal-title":"Am J Nephrol"},{"issue":"1","key":"1408_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst reviews. 2015;4(1):1\u20139.","journal-title":"Syst reviews"},{"key":"1408_CR23","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group* P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139.","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"1408_CR24","unstructured":"Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. 2011;2(1):1\u201312."},{"issue":"11","key":"1408_CR25","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"7414","key":"1408_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"key":"1408_CR27","doi-asserted-by":"crossref","unstructured":"Arersa KK, Wondimnew T, Welde M, Husen TM. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients attending Jimma Medical Center, Ethiopia S. 2019. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020;13:2059.","DOI":"10.2147\/DMSO.S252825"},{"issue":"1","key":"1408_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-017-0226-y","volume":"17","author":"SB Woyesa","year":"2017","unstructured":"Woyesa SB, Hirigo AT, Wube TB. Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia. BMC Endocr disorders. 2017;17(1):1\u20138.","journal-title":"BMC Endocr disorders"},{"issue":"3","key":"1408_CR29","first-page":"325","volume":"30","author":"B Woldeamlak","year":"2019","unstructured":"Woldeamlak B, Yirdaw K, Biadgo B. Hyperuricemia and its association with cardiovascular disease risk factors in type two diabetes mellitus patients at the University of Gondar Hospital, Northwest Ethiopia. EJIFCC. 2019;30(3):325.","journal-title":"EJIFCC"},{"key":"1408_CR30","volume-title":"Serum uric acid levels in patients with type 2 diabetes at","author":"M Shokat","year":"2018","unstructured":"Shokat M. Serum uric acid levels in patients with type 2 diabetes at. Kenyatta National Hospital: University of Nairobi; 2018."},{"issue":"3","key":"1408_CR31","first-page":"25","volume":"8","author":"J Uwakwe","year":"2014","unstructured":"Uwakwe J, Agboghoroma O, Akanbi F, Odoh G, Puepet F. Hyperuricaemia in obese type 2 diabetics in Jos, north central Nigeria. Jos J Med. 2014;8(3):25\u20139.","journal-title":"Jos J Med"},{"issue":"1","key":"1408_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-5996-2-1","volume":"2","author":"AO Ogbera","year":"2010","unstructured":"Ogbera AO, Azenabor AO. Hyperuricaemia and the metabolic syndrome in type 2 DM. Diabetol Metab Syndr. 2010;2(1):1\u20138.","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"1408_CR33","first-page":"137","volume":"10","author":"A Akande","year":"2007","unstructured":"Akande A, Jimoh A, Akinyinka O, Olarinoye G. Serum uric acid level as an independent component of the metabolism syndrome in type 2 diabetic blacks. Niger J Clin Pract. 2007;10(2):137\u201342.","journal-title":"Niger J Clin Pract"},{"issue":"3","key":"1408_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5897\/AJBR2020.1111","volume":"15","author":"NOK Barry","year":"2021","unstructured":"Barry NOK, Djite M, Kandji PM, Ndour MA, Diedhiou D, Fatou G-T, et al. Association of hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients in Dakar. Afr J Biochem Res. 2021;15(3):43\u20138.","journal-title":"Afr J Biochem Res"},{"key":"1408_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.5935\/0101-2800.20160065","volume":"38","author":"M Fouad","year":"2016","unstructured":"Fouad M, Fathy H, Zidan A. Serum uric acid and its association with hypertension, early nephropathy and chronic kidney disease in type 2 diabetic patients. Brazilian J Nephrol. 2016;38:403\u201310.","journal-title":"Brazilian J Nephrol"},{"issue":"1","key":"1408_CR36","first-page":"12","volume":"2020","author":"H Fennoun","year":"2020","unstructured":"Fennoun H, Haraj N, El Aziz S, Bensbaa S, Chadli A. Risk factors associated with hyperuricemia in patients with diabetes type 2: about 190 cases. Diabetes Research: Open Access. 2020;2020(1):12.","journal-title":"Diabetes Research: Open Access"},{"issue":"3","key":"1408_CR37","first-page":"493","volume":"7","author":"HO Mirghani","year":"2018","unstructured":"Mirghani HO. Hypertriglyceridemia, hyperuricemia, and anemia among sudanese patients with type 2 diabetes mellitus. Indian J Basic Appl Med Res. 2018;7(3):493\u2013501.","journal-title":"Indian J Basic Appl Med Res"},{"issue":"4","key":"1408_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/0049475515626030","volume":"46","author":"S-P Choukem","year":"2016","unstructured":"Choukem S-P, Mengue J-A, Doualla M-S, Donfack O-T, Beyiha G, Luma HN. Hyperuricaemia in patients with type 2 diabetes in a tertiary healthcare centre in sub-saharan Africa: prevalence and determinants. Trop Doct. 2016;46(4):216\u201321.","journal-title":"Trop Doct"},{"key":"1408_CR39","unstructured":"Donkeng M, Kuat\u00e9 D, Koudjou PN, Noubiap JJ, Kuiate JR. Association between hyperuricemia and glycated hemoglobin in type 2 diabetes at the District Hospital of Dschang. Pan Afr Med J. 2021;40."},{"issue":"1","key":"1408_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4102\/ajlm.v8i1.786","volume":"8","author":"E Gobusamang","year":"2019","unstructured":"Gobusamang E, Motswaledi MS, Kasvosve I, Nyepetsi NG. Hyperuricaemia is associated with dyslipidemia but not HbA1c among type 2 diabetes mellitus patients in Botswana. Afr J Lab Med. 2019;8(1):1\u20134.","journal-title":"Afr J Lab Med"},{"issue":"10322","key":"1408_CR41","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0140-6736(21)01919-X","volume":"399","author":"I Lingvay","year":"2022","unstructured":"Lingvay I, Sumithran P, Cohen RV, le Roux CW. Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation. The Lancet. 2022;399(10322):394\u2013405.","journal-title":"The Lancet"},{"issue":"4","key":"1408_CR42","first-page":"170","volume":"20","author":"F Mulita","year":"2021","unstructured":"Mulita F, Lampropoulos C, Kehagias D, Verras G-I, Tchabashvili L, Kaplanis C, et al. Long-term nutritional deficiencies following sleeve gastrectomy: a 6-year single-centre retrospective study. Menopause Review\/Przegl\u00c4 d Menopauzalny. 2021;20(4):170\u20136.","journal-title":"Menopause Review\/Przegl\u00c4 d Menopauzalny"},{"key":"1408_CR43","doi-asserted-by":"crossref","unstructured":"Lampropoulos C, Mulita F, Alexandrides T, Kehagias D, Kalavrizioti D, Albanopoulos K et al. Ghrelin, glucagon-like peptide-1, and peptide YY secretion in patients with and without weight regain during long-term follow-up after bariatric surgery: a cross-sectional study. Menopause Review\/Przegl\u00c4 d Menopauzalny. 2022;21(1).","DOI":"10.5114\/pm.2022.116492"},{"key":"1408_CR44","doi-asserted-by":"crossref","unstructured":"Xiong Q, Liu J, Xu Y. Effects of uric acid on diabetes mellitus and its chronic complications. International journal of endocrinology. 2019;2019.","DOI":"10.1155\/2019\/9691345"},{"issue":"10","key":"1408_CR45","doi-asserted-by":"publisher","first-page":"e78206","DOI":"10.1371\/journal.pone.0078206","volume":"8","author":"Y Xu","year":"2013","unstructured":"Xu Y, Zhu J, Gao L, Liu Y, Shen J, Shen C, et al. Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis. PLoS ONE. 2013;8(10):e78206.","journal-title":"PLoS ONE"},{"issue":"2","key":"1408_CR46","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/HJH.0b013e3282f240bf","volume":"26","author":"DB Corry","year":"2008","unstructured":"Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin\u2013angiotensin system. J Hypertens. 2008;26(2):269\u201375.","journal-title":"J Hypertens"},{"key":"1408_CR47","unstructured":"Shah P, Bjornstad P, Johnson RJ. Hyperuricemia as a potential risk factor for type 2 diabetes and diabetic nephropathy. SciELO Brasil; 2016. pp. 386\u20137."},{"issue":"6","key":"1408_CR48","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/0026-0495(81)90142-6","volume":"30","author":"IH Fox","year":"1981","unstructured":"Fox IH. Metabolic basis for disorders of purine nucleotide degradation. Metabolism. 1981;30(6):616\u201334.","journal-title":"Metabolism"},{"key":"1408_CR49","doi-asserted-by":"crossref","unstructured":"Karam JH, Grodsky GM. Insulin Content of Pancreas after Sodium Fluoroacetate-Induced Hyperglycemia. Proceedings of the Society for Experimental Biology and Medicine. 1962;109(2):451-4.","DOI":"10.3181\/00379727-109-27233"},{"issue":"4","key":"1408_CR50","first-page":"590","volume":"22","author":"J Wang","year":"2013","unstructured":"Wang J, Chen R-P, Lei L, Song Q-Q, Zhang R-Y, Li Y-B, et al. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong Province in China. Asia Pac J Clin Nutr. 2013;22(4):590\u20138.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"1","key":"1408_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-11-1","volume":"11","author":"B Liu","year":"2011","unstructured":"Liu B, Wang T, Zhao H, Yue W, Yu H, Liu C, et al. The prevalence of hyperuricemia in China: a meta-analysis. BMC Public Health. 2011;11(1):1\u201310.","journal-title":"BMC Public Health"},{"issue":"5","key":"1408_CR52","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/imj.13006","volume":"46","author":"K Ting","year":"2016","unstructured":"Ting K, Gill T, Keen H, Tucker G, Hill C. Prevalence and associations of gout and hyperuricaemia: results from an australian population-based study. Intern Med J. 2016;46(5):566\u201373.","journal-title":"Intern Med J"},{"issue":"1","key":"1408_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"X-B Huang","year":"2020","unstructured":"Huang X-B, Zhang W-Q, Tang W-W, Liu Y, Ning Y, Huang C, et al. Prevalence and associated factors of hyperuricemia among urban adults aged 35\u201379 years in southwestern China: a community-based cross-sectional study. Sci Rep. 2020;10(1):1\u20137.","journal-title":"Sci Rep"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01408-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-023-01408-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01408-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T05:02:13Z","timestamp":1689656533000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-023-01408-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,18]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1408"],"URL":"https:\/\/doi.org\/10.1186\/s12902-023-01408-0","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,18]]},"assertion":[{"value":"27 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that no competing interest for their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}